Key Takeaways Tempus partnered with Northwestern to use its Lens platform in Alzheimer's genomic research. TEM teamed up with Boehringer Ingelheim to expand cancer pipeline research using AI insights.Tempus also collaborated with Stemline and Genialis to advance oncology treatments with AI platforms.Tempus AI, Inc. (TEM) is rapidly expanding its partnerships across oncology and neuroscience, leveraging its AI platforms — Lens and Next — to accelerate precision medicine.Tempus has entered into a multi-year c ...